Related Experiment Videos
Pelizaeus-Merzbacher disease: classical or connatal?
I E Scheffer1, M Baraitser, J Wilson
1Department of Neurology, Hospital for Sick Children, London, England.
Neuropediatrics
|May 1, 1991
Summary
Pelizaeus-Merzbacher disease (PMD) presents with early stridor and nystagmus. The severe connatal form causes rapid decline, while the classical form shows slower progression with prominent cerebellar and cognitive issues.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare, progressive, white matter disorder.
- Distinguishing between PMD subtypes is crucial for prognosis and management.
Purpose of the Study:
- To differentiate the clinical features of connatal and classical Pelizaeus-Merzbacher disease.
- To identify early clinical indicators for each PMD subtype.
Main Methods:
- Clinical case series of 7 patients with Pelizaeus-Merzbacher disease.
- Review of clinical features, brain biopsy, autopsy findings, neuroimaging (MRI), and brainstem auditory evoked potentials (BAEPs).
Main Results:
- Transient stridor and nystagmus are early signs in both PMD types.
- Connatal PMD: rapid neurological deterioration, feeding problems, extrapyramidal features, early death.
- Classical PMD: prominent cerebellar signs, cognitive decline, slower progression.
Conclusions:
- Early clinical signs can suggest PMD subtypes, aiding diagnosis.
- MRI and BAEPs support PMD diagnosis but not subtype differentiation.
- Genetic counseling for PMD is challenging due to variable inheritance patterns.